Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Cardiovascular Systems Inc Company Overview 4
Cardiovascular Systems Inc Company Snapshot 4
Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Cardiovascular Systems Inc – Pipeline Analysis Overview 7
Cardiovascular Systems Inc – Key Facts 7
Cardiovascular Systems Inc – Major Products and Services 8
Cardiovascular Systems Inc Pipeline Products by Development Stage 9
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status 11
Cardiovascular Systems Inc Pipeline Products Overview 13
Diamondback 360 Coronary OAS Micro Crown 13
Diamondback 360 Coronary OAS Micro Crown Product Overview 13
Diamondback 360 Coronary Orbital Atherectomy System 14
Diamondback 360 Coronary Orbital Atherectomy System Product Overview 14
Diamondback 360 Coronary Orbital Atherectomy System Clinical Trial 15
Diamondback 360 Peripheral Orbital Atherectomy System 16
Diamondback 360 Peripheral Orbital Atherectomy System Product Overview 16
Diamondback 360 Peripheral Orbital Atherectomy System Clinical Trial 17
Cardiovascular Systems Inc – Key Competitors 18
Cardiovascular Systems Inc – Key Employees 19
Cardiovascular Systems Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Cardiovascular Systems Inc, Recent Developments 21
Oct 25, 2017: Cardiovascular Systems Reports Fiscal 2018 First-Quarter Financial Results 21
Sep 18, 2017: Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma 22
Sep 11, 2017: Lesion Preparation Using Diamondback 360 Orbital Atherectomy System Enhances Paclitaxel Distribution in Calcified Peripheral Arteries 22
Aug 10, 2017: LIBERTY 360° Study 12-Month Data Demonstrate Lasting Benefits Following Endovascular Intervention in Patients with Critical Limb Ischemia 23
Aug 10, 2017: LIBERTY 360° Study 12-Month Sub-Analysis Reveals High Freedom from Major Amputation and Major Adverse Events (MAE) Using Cardiovascular Systems’ Diamondback 360 Peripheral Orbital Atherectomy System (OAS) 24
Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results 24
May 04, 2017: FDA Approves Cardiovascular Systems’ Replacement Saline Infusion Pump 26
May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results 26
Apr 17, 2017: Cardiovascular Systems Initiates Voluntary Recall of Saline Infusion Pump 27
Mar 30, 2017: Cardiovascular Systems Receives Approval for the Diamondback 360 Coronary Orbital Atherectomy System Micro Crown in the United States 28
Appendix 29
Methodology 29
About GlobalData 31
Contact Us 31
Disclaimer 32
Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Cardiovascular Systems Inc Pipeline Products by Equipment Type 5
Cardiovascular Systems Inc Pipeline Products by Indication 6
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status 6
Cardiovascular Systems Inc, Key Facts 7
Cardiovascular Systems Inc, Major Products and Services 8
Cardiovascular Systems Inc Number of Pipeline Products by Development Stage 9
Cardiovascular Systems Inc Pipeline Products Summary by Development Stage 10
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status 11
Cardiovascular Systems Inc Ongoing Clinical Trials Summary 12
Diamondback 360 Coronary OAS Micro Crown - Product Status 13
Diamondback 360 Coronary OAS Micro Crown - Product Description 13
Diamondback 360 Coronary Orbital Atherectomy System - Product Status 14
Diamondback 360 Coronary Orbital Atherectomy System - Product Description 14
Diamondback 360 Coronary Orbital Atherectomy System - Comparison of Orbital Versus Rotational Atherectomy Effects on Coronary Microcirculation in Percutaneous Coronary Intervention (PCI) 15
Diamondback 360 Coronary Orbital Atherectomy System - Evaluation of Treatment Strategies for Severe CalcIfic Coronary Arteries: Orbital Atherectomy versus Conventional Angioplasty Technique Prior to Implantation of Drug-eluting Stents: The ECLIPSE Trial 15
Diamondback 360 Peripheral Orbital Atherectomy System - Product Status 16
Diamondback 360 Peripheral Orbital Atherectomy System - Product Description 16
Diamondback 360 Peripheral Orbital Atherectomy System - Orbital Vessel Preparation to Maximize DCB Efficacy in Calcified below the Knee (BTK) Lesions - A Pilot Study 17
Diamondback 360 Peripheral Orbital Atherectomy System - Prospective, Observational, Multi-center Clinical Study to Evaluate Acute and Long Term Clinical and Economic Outcomes of Endovascular Device Intervention in Patients with Distal Outflow Peripheral Arterial Disease (PAD): LIBERTY 360 17
Cardiovascular Systems Inc, Key Employees 19
Glossary 30